Home › Chemotherapy › Mitomycin and Actinomycin: — What These Drugs Do and What to Watch For

Chemotherapy drugs

Mitomycin and Actinomycin: What These Drugs Do and What to Watch For

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Mitomycin and actinomycin (dactinomycin) are established chemotherapy medicines used for specific cancers. Both carry serious side effects — particularly delayed effects on the bone marrow — and both are given only in a hospital or day care setting under specialist supervision.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Prescription-only medicine.

Mitomycin and dactinomycin are prescription-only medicines that can be given only by a trained specialist in a hospital or day care setting. Nothing on this page can or should be used to start, adjust, or stop any medicine. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Mitomycin and dactinomycin (actinomycin D) are chemotherapy drugs used for specific cancers — bladder, anal canal, Wilms tumour, gestational trophoblastic disease and certain sarcomas. Both can suppress the bone marrow, and mitomycin's effect on blood counts is often delayed by several weeks. Both are given only in hospital under specialist supervision.

In detail

What cancers are mitomycin and actinomycin used for?

Mitomycin (mitomycin C; brand names include Mitocin) is used in bladder cancer given directly into the bladder, anal canal cancer given alongside radiotherapy, stomach cancer, and some head and neck cancers. It is an alkylating agent — a type of chemotherapy that works by damaging the DNA inside cancer cells.

Dactinomycin (actinomycin D; brand name Cosmegen) is used mainly in Wilms tumour, gestational trophoblastic disease, rhabdomyosarcoma and Ewing sarcoma. It is part of the standard approach for these diagnoses according to NCCN and ESMO guidance, particularly in children and young adults.

Both are given as an intravenous infusion in a hospital or day care setting. Mitomycin for bladder cancer is sometimes instilled directly into the bladder through a catheter — in that case it acts mainly on the bladder lining rather than circulating through the whole body.

Checklist

Side effects to tell your team about

Unusual bruising, bleeding gums, or a small cut that will not stop — platelets may be low; call your team the same day
Fever, chills, or more infections than usual — white cell count may be low; any fever above 38°C needs same-day assessment
Severe tiredness, pallor or breathlessness — red cell count may be low; with mitomycin the nadir is often delayed by several weeks
New cough or worsening shortness of breath — lung inflammation has been reported with mitomycin and needs prompt review
Mouth sores, difficulty swallowing, or significant diarrhoea — dactinomycin in particular causes intense gut and mouth lining reactions
Skin redness, blistering or pain in an area that previously received radiotherapy — this is radiation recall; report it the same day
Swollen or tender abdomen, especially in children receiving dactinomycin — liver inflammation needs urgent assessment
Any burning, swelling or pain at the infusion site during or after the drip — tell the nurse present immediately

Eligibility

Who these medicines are not for

Both mitomycin and dactinomycin are withheld or used only with extreme caution in certain situations. Eligibility is decided by an oncologist for each individual patient on the basis of their specific test results and clinical history.

Severely reduced kidney function, because the drug clears more slowly and toxic effects accumulate
Very low blood counts at the start of treatment
A history of serious bleeding disorders
Prior mitomycin treatment that has reached the safe cumulative limit
Active chickenpox or shingles, because it can cause life-threatening spread of the virus
Significantly reduced liver function
Very young infantsLiver toxicity risk is higher in this group, and the treating paediatric oncologist sets the threshold individually

Neither medicine is routinely used in pregnancy. Dactinomycin may be part of the indicated regimen for gestational trophoblastic disease, which is a pregnancy-related tumour, but this is managed under specialist guidance on an individual basis.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

At a glance

Words you may see on your treatment plan

IntravesicalGiven directly into the bladder through a short catheter, so the drug acts mainly on the bladder lining without entering the bloodstream in large amounts. The bone marrow effects of intravenous mitomycin are much less likely with intravesical delivery.

VesicantA drug that can damage the skin and underlying tissue if it leaks from the vein during infusion. Both mitomycin and dactinomycin carry this risk. Tell the nurse immediately if you feel burning or pain at the infusion site — do not wait until after the drip is finished.

Radiation recallA skin or tissue reaction that appears in an area previously treated with radiotherapy, triggered by a later chemotherapy dose. It can occur months or even years after the radiation course ended. Dactinomycin is one of the agents most associated with this reaction.

MyelosuppressionA reduction in the bone marrow's ability to produce blood cells — red cells, white cells and platelets. It raises the risk of infection, fatigue and unusual bleeding. Monitoring blood counts regularly during treatment lets your team manage this safely.

Delayed nadirThe point when blood counts reach their lowest level. Mitomycin's nadir is often delayed — appearing three to five weeks after the dose — which is later than for many other chemotherapy agents. Your team plans the schedule of blood tests to account for this.

HUS (haemolytic uraemic syndrome)A rare but serious complication reported with mitomycin, involving damage to small blood vessels in the kidneys and breakdown of red blood cells. Very dark, smoky or blood-coloured urine during or after treatment needs urgent review, not a wait-and-see approach.

In detail

Why are these drugs described as less common?

Neither mitomycin nor dactinomycin is rare — each is the standard treatment within its own specific indications. They are described as less common because each is used for a narrow set of cancer types, and outside those indications oncologists do not prescribe them.

Mitomycin's use declined in some settings as newer treatments showed similar results with better tolerability. It remains standard because, for anal canal cancer and non-muscle-invasive bladder cancer, NCCN and ESMO guidance continues to include it as part of the recommended approach.

If you are receiving one of these medicines, it was chosen because the evidence supports it for your specific diagnosis. Being less familiar does not mean being inferior — it means the drug fits a narrower set of situations, and yours is one of them.

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Why has my doctor prescribed mitomycin when newer chemotherapy drugs exist?

For specific cancers — particularly anal canal cancer and non-muscle-invasive bladder cancer — mitomycin remains part of the approach recommended by NCCN and ESMO guidance because the evidence continues to support it for those situations. Prescribing is not based on availability or tradition alone; it reflects what the data shows for your cancer type and stage. If you want to understand the reasoning, ask your oncologist which alternatives were considered and why this regimen was preferred over them.

How long does the bone marrow suppression from mitomycin last?

Mitomycin's effect on the bone marrow is cumulative and delayed. The blood count nadir — when white cells, red cells and platelets are at their lowest — typically appears three to five weeks after the dose, later than the one to two weeks seen with most other chemotherapy agents. Blood tests are scheduled with this pattern in mind. If you notice worsening tiredness, unusual bruising, or repeated infections between appointments, contact your team the same day rather than waiting for your next scheduled test.

What is radiation recall and is it dangerous?

Radiation recall is a skin or tissue reaction in an area you previously had radiotherapy, triggered by a chemotherapy dose given weeks, months or even years later. Dactinomycin is one of the agents most associated with it. It can range from redness and soreness to blistering. It is not a sign that the cancer has come back. It is treatable, but it needs to be assessed by your team — do not apply creams or dressings to the affected area without asking them first.

Can mitomycin be given at home or as a tablet?

No. Mitomycin is given only in a hospital or day care setting by trained nursing staff under specialist supervision. It requires careful preparation, and it carries a risk of tissue damage if it leaks from the vein. For bladder cancer, intravesical mitomycin is instilled by a clinical team in a urology day care setting, not at home. There is no oral tablet form of mitomycin available for cancer treatment.

My child is receiving dactinomycin — is it particularly harsh?

Dactinomycin can cause significant side effects, particularly inflammation of the gut and mouth lining, and it carries a risk of liver inflammation that is higher in young children. Your child's oncology team will monitor liver function during treatment and has planned the schedule with this in mind. Radiation recall and liver toxicity are the two things to watch most carefully. If your child has had radiotherapy, tell their team even if it was some time ago. Ask which symptoms should prompt an immediate call rather than waiting for the next appointment.

What is the difference between mitomycin given into the bladder and mitomycin given by drip?

When mitomycin is given directly into the bladder through a catheter — called intravesical delivery — most of the drug acts on the bladder lining and very little enters the bloodstream. The bone marrow suppression and kidney effects associated with intravenous mitomycin are much less likely this way. Side effects with intravesical mitomycin are mainly local: bladder irritation, a burning sensation when passing urine, and occasionally a skin rash if the drug contacts skin during the procedure. Both routes are given in a clinical setting by trained staff.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index